GGrantIndex
← Leaderboards

Thomas L Ortel

Duke University

Google Scholar ↗PubMed ↗ORCID ↗
$32,805,539
Attributed
$32,805,539
Total exposure
11
Grants
8
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).

Funding over time

peak $6.4M · FY2005–25
$10M$7.5M$5M$2.5M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$37,628,485 · 9
CDC$2,331,622 · 4

By mechanism

U01$24,347,088 · 3
U54$11,199,526 · 2
U2C$1,415,714 · 1
U50$750,000 · 1
U34$700,248 · 1
M01$699,208 · 2

Top collaborators

Most similar at Duke University

Same institution · by research overlap

Others in their field

Top investigators on “Clinical Research”

Research focus

Clinical ResearchHuman SubjectClinical TrialsAntiphospholipid SyndromeAutoantibodyThrombosisThrombocytopeniaGuidelinesHuman Therapy EvaluationProspectiveMolecular PathologyAutoimmune DisorderCollegeEnrollmentRecruitment ActivityPhysiciansEventDisease /Disorder Proneness /RiskAnticoagulationAnticoagulant TherapyAnticoagulantsExclusion CriteriaData Coordinating CenterChest

Grant awards (53)

U2C/TL1 NC KUH TRIO Program$488,177
U2C · FY2025 · DK
U2C/TL1 NC KUH TRIO Program$439,360
U2C · FY2024 · DK
U2C/TL1 NC KUH TRIO Program$488,177
U2C · FY2023 · DK
Anticoagulation Withdrawal in Antiphospholipid Syndrome$207,042
U34 · FY2016 · HL · contact PI
Anticoagulation Withdrawal in Antiphospholipid Syndrome$242,075
U34 · FY2015 · HL · contact PI
BRIDGE TRIAL$2,862,492
U01 · FY2014 · HL · contact PI
Anticoagulation Withdrawal in Antiphospholipid Syndrome$251,131
U34 · FY2014 · HL · contact PI
POPULATION-BASED SURVEILLANCE AND OUTCOMES OF VENOUS THROMBOEMBOLISM$150,000
U50 · FY2014 · DD · contact PI
BRIDGE TRIAL$4,537,014
U01 · FY2013 · HL · contact PI
POPULATION-BASED SURVEILLANCE AND OUTCOMES OF VENOUS THROMBOEMBOLISM$300,000
U50 · FY2013 · DD · contact PI
Promoting the Health of People with Clotting Disorders$206,622
U27 · FY2013 · DD · contact PI
POPULATION-BASED SURVEILLANCE AND OUTCOMES OF VENOUS THROMBOEMBOLISM$300,000
U50 · FY2012 · DD · contact PI
Transfusion Medicine/Hemostasis Core Clinical Center$170,625
U01 · FY2012 · HL · contact PI
Thrombosis and Hemostasis Centers Research and Prevention Network$175,000
U01 · FY2011 · DD · contact PI
BRIDGE TRIAL$4,673,187
U01 · FY2010 · HL · contact PI
Thrombosis and Hemostasis Centers Research and Prevention Network$200,000
U01 · FY2010 · DD · contact PI
BRIDGE TRIAL$5,132,543
U01 · FY2009 · HL · contact PI
Thrombosis and Hemostasis Centers Research and Prevention Network$280,000
U01 · FY2009 · DD · contact PI
Transfusion Medicine/Hemostasis Core Clinical Center$195,000
U01 · FY2009 · HL · contact PI
BRIDGE TRIAL$3,963,283
U01 · FY2008 · HL · contact PI
Rare Thrombotic Diseases Clinical Research Network$1,159,232
U54 · FY2008 · HL · contact PI
Genetics of antiphospholipid antibody syndromes$1,008,884
U54 · FY2008 · HL · contact PI
Thrombosis and Hemostasis Centers Research and Prevention Network$220,000
U01 · FY2008 · DD · contact PI
Rare Thrombotic Diseases Clinical Research Network$1,163,702
U54 · FY2007 · HL · contact PI
Genetics of Antiphospholipid Antibody Syndromes$1,006,777
U54 · FY2007 · HL · contact PI
Thrombosis and Hemostasis Centers Research and Prevention Network$250,000
U01 · FY2007 · DD · contact PI
Transfusion Medicine/Hemostasis Core Clinical Center$195,000
U01 · FY2007 · HL · contact PI
Genetics of antiphospholipid antibody syndromes$1,237,883
U54 · FY2006 · HL · contact PI
Rare Thrombotic Diseases Clinical Research Network$1,208,792
U54 · FY2006 · HL · contact PI
Transfusion Medicine/Hemostasis Core Clinical Center$292,948
U01 · FY2006 · HL · contact PI
Integrated Program for Persons with Hemostatic Disorders$250,000
U18 · FY2006 · DD · contact PI
Genetics of antiphospholipid antibody syndromes$1,229,410
U54 · FY2005 · HL
Rare Thrombotic Diseases Clinical Research Network$1,229,410
U54 · FY2005 · HL
Transfusion Medicine/Hemostasis Core Clinical Center$299,999
U01 · FY2005 · HL
MULTI-DOSE PHARMACOKINETIC STUDY OF DALTEPARIN IN HEMODIALYSIS PATIENTS$20,398
M01 · FY2005 · RR
Integrated Program for Persons with Hemostatic Disorders$0
U18 · FY2005 · DD
Rare Thrombotic Diseases Clinical Research Network$977,718
U54 · FY2004 · HL
Genetics of antiphospholipid antibody syndromes$977,718
U54 · FY2004 · HL
Transfusion Medicine/Hemostasis Core Clinical Center$299,999
U01 · FY2004 · HL
Pharmacokinetic Study of Dalteparin in Hemodialysis$34,675
M01 · FY2004 · RR
Integrated Program for Persons with Hemostatic Disorders$0
U18 · FY2004 · DD
Transfusion Medicine/Hemostasis Core Clinical Center$299,999
U01 · FY2003 · HL
PATHOPHYSIOLOGY OF ANTIPHOSPHOLIPID ANTIBODY SYNDROMES$101,607
K24 · FY2003 · AI
Transfusion Medicine/Hemostasis Core Clinical Center$299,999
U01 · FY2002 · HL
GENETIC ANALYSIS OF ANTIPHOSPHOLIPID ANTIBODY SYNDROMES$117,022
M01 · FY2002 · RR
PATHOPHYSIOLOGY OF ANTIPHOSPHOLIPID ANTIBODY SYNDROMES$99,249
K24 · FY2002 · AI
GENETIC ANALYSIS OF ANTIPHOSPHOLIPID ANTIBODY SYNDROMES$293,069
M01 · FY2001 · RR
GENETIC ANALYSIS OF ANTIPHOSPHOLIPID ANTIBODY SYNDROMES$117,022
M01 · FY2001 · RR
GENETIC ANALYSIS OF ANTIPHOSPHOLIPID ANTIBODY SYNDROMES$117,022
M01 · FY2001 · RR
PATHOPHYSIOLOGY OF ANTIPHOSPHOLIPID ANTIBODY SYNDROMES$96,434
K24 · FY2001 · AI
PATHOPHYSIOLOGY OF ANTIPHOSPHOLIPID ANTIBODY SYNDROMES$94,411
K24 · FY2000 · AI
GENETIC ANALYSIS OF ANTIPHOSPHOLIPID ANTIBODY SYNDROMES$0
M01 · FY2000 · RR
GENETIC ANALYSIS OF ANTIPHOSPHOLIPID ANTIBODY SYNDROMES$0
M01 · FY2000 · RR